SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QCOM

Go back to SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
(NASDAQ: SPRC) Delayed: 5.10 -0.19 (3.59%)
Previous Close $5.29    52 Week High $ 
Open $5.18    52 Week Low $ 
Day High $5.35    P/E N/A 
Day Low $5.06    EPS $ 
Volume 6,962       

(NASDAQ: SPRC) Delayed: 5.10 -0.19 (3.59%)
Previous Close $5.29    52 Week High $ 
Open $5.18    52 Week Low $ 
Day High $5.35    P/E N/A 
Day Low $5.06    EPS $ 
Volume 6,962